Fangzhen Shan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fangzhen Shan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Nannan Zhang
Medical Research Centre, Affiliated Hospital of Jining Medical University, Jining, China
5 shared publications- Xiaoming Tu
Univ Sci & Technol China, Hefei Natl Res Ctr Interdisciplinary Sci Microscal, Sch Life Sci, MOE Key Lab Membraneless Organelles & Cellular Dyn, Hefei 230022, Anhui, Peoples R China
5 shared publications Jiahai Zhang
Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, China
3 shared publications- Nannan Zhang
Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Jining Medical University, Jining, China
3 shared publications Qian Zheng
Medical Research Centre, Affiliated Hospital of Jining Medical University, Jining, China
3 shared publicationsXuecheng Zhang
School of Life Sciences, Anhui University, Hefei, Anhui 230039, China
3 shared publications
Latest Publications
- Open Access
- 6 December 2025
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
SYK regulates Schwann cell metabolic reprogramming to promote axonal regeneration in immune-mediated neuropathy
Immune-mediated peripheral neuropathies like acute motor axonal neuropathy (AMAN) drive axonal degeneration through unresolved neuroinflammation, where Sch
- 6 December 2025
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
Open AccessSYK regulates Schwann cell metabolic reprogramming to promote axonal regeneration in immune-mediated neuropathy
Immune-mediated peripheral neuropathies like acute motor axonal neuropathy (AMAN) drive axonal degeneration through unresolved neuroinflammation, where Sch
- Open Access
- 16 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
NMDA Receptors Coordinate Metabolic Reprogramming and Mitophagy in Schwann Cells to Promote Peripheral Nerve Regeneration
Schwann cells (SCs) are indispensable for peripheral nerve regeneration, yet the mechanisms enabling their metabolic adaptation to meet the energetic demands of axonal repair remain elusive. Here, we identify N-methyl-D-aspartate (NMDA) receptors as central regulators of SC metabolic plasticity. In a mouse model of acute motor axonal neuropathy, nerve injury led to a marked decrease in NMDA receptor expression on SC. Functional studies revealed that NMDA receptors mediate calcium influx to drive glycolysis and oxidative phosphorylation via the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin and hypoxia-inducible factor-1α/c-Myc pathways, ensuring adenosine triphosphate production for axonal repair. Simultaneously, NMDA receptors orchestrate ataxia telangiectasia-mutated and Rad3-related protein–autophagy related 13-dependent mitophagy to clear reactive oxygen species-damaged mitochondria, maintaining metabolic efficiency during energy stress. Targeted metabolomics, Seahorse flux, and molecular pathological analysis revealed NMDA receptor-dependent remodeling of glucose metabolism, tricarboxylic acid cycle, nucleotide synthesis, and mitochondrial ultrastructure in SC. NMDA receptor deficiency disrupts energy metabolism and impairs axonal survival following sciatic nerve injury, resulting in aggravated neurological deficits and hindered nerve regeneration. Crucially, NMDA receptor activation rescued axonal integrity and motor function in mice with acute motor axonal neuropathy, underscoring their therapeutic potential. Our findings establish NMDA receptors as dual regulators of SC energy metabolism and mitochondrial quality control, providing a novel strategy to enhance glia-axonal metabolic coupling in peripheral neuropathies.
- 16 July 2025
- Published by American Association for the Advancement of Science (AAAS) in Research
- Vol. 8
Open AccessNMDA Receptors Coordinate Metabolic Reprogramming and Mitophagy in Schwann Cells to Promote Peripheral Nerve Regeneration
Schwann cells (SCs) are indispensable for peripheral nerve regeneration, yet the mechanisms enabling their metabolic adaptation to meet the energetic demands of axonal repair remain elusive. Here, we identify N-methyl-D-aspartate (NMDA) receptors as central regulators of SC metabolic plasticity. In a mouse model of acute motor axonal neuropathy, nerve injury led to a marked decrease in NMDA receptor expression on SC. Functional studies revealed that NMDA receptors mediate calcium influx to drive glycolysis and oxidative phosphorylation via the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin and hypoxia-inducible factor-1α/c-Myc pathways, ensuring adenosine triphosphate production for axonal repair. Simultaneously, NMDA receptors orchestrate ataxia telangiectasia-mutated and Rad3-related protein–autophagy related 13-dependent mitophagy to clear reactive oxygen species-damaged mitochondria, maintaining metabolic efficiency during energy stress. Targeted metabolomics, Seahorse flux, and molecular pathological analysis revealed NMDA receptor-dependent remodeling of glucose metabolism, tricarboxylic acid cycle, nucleotide synthesis, and mitochondrial ultrastructure in SC. NMDA receptor deficiency disrupts energy metabolism and impairs axonal survival following sciatic nerve injury, resulting in aggravated neurological deficits and hindered nerve regeneration. Crucially, NMDA receptor activation rescued axonal integrity and motor function in mice with acute motor axonal neuropathy, underscoring their therapeutic potential. Our findings establish NMDA receptors as dual regulators of SC energy metabolism and mitochondrial quality control, providing a novel strategy to enhance glia-axonal metabolic coupling in peripheral neuropathies.
- 16 March 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (5) , 167804
Electrical stimulation promotes peripheral nerve regeneration by upregulating glycolysis and oxidative phosphorylation
- 16 March 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1871 (5) , 167804
Electrical stimulation promotes peripheral nerve regeneration by upregulating glycolysis and oxidative phosphorylation
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (3) , 213-219
Elevated Serum Amyloid A2 and A4 in Patients With Guillain–Barré Syndrome
Yao X, et al. J Clin Neurol. 2025 Mar;21:e12. https://doi.org/10.3988/jcn.2024.0469
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (3) , 213-219
Open AccessElevated Serum Amyloid A2 and A4 in Patients With Guillain–Barré Syndrome
Yao X, et al. J Clin Neurol. 2025 Mar;21:e12. https://doi.org/10.3988/jcn.2024.0469
- Top Cited PapersOpen Access
- 7 March 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (3) , 1-17
TREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits
Triggering receptor expressed on myeloid cells-2 (TREM2) has been implicated in susceptibility to neurodegenerative disease. Schwann cells (SCs), the predominant glial cell type in the peripheral nervous system (PNS), play a crucial role in myelination, providing trophic support for neurons and nerve regeneration. However, the function of TREM2 in SCs has not been fully elucidated. Here, we found that TREM2 is expressed in SCs but not in neurons in the PNS. TREM2 deficiency leads to disruption of glycolytic flux and oxidative metabolism in SCs, impairing cell proliferation. The energy crisis caused by TREM2 deficiency triggers mitochondrial damage and autophagy by activating AMPK and impairing PI3K-AKT-mTOR signaling. Combined metabolomic analysis demonstrated that energic substrates and energy metabolic pathways were significantly impaired in TREM2-deficient SCs. Moreover, TREM2 deficiency impairs energy metabolism and axonal growth in sciatic nerve, accompanied by exacerbation of neurological deficits and suppression of nerve regeneration in a mouse model of acute motor axonal neuropathy. These results indicate that TREM2 is a critical regulator of energy metabolism in SCs and exerts neuroprotective effects on peripheral neuropathy.
- 7 March 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (3) , 1-17
Top Cited PapersOpen AccessTREM2 deficiency impairs the energy metabolism of Schwann cells and exacerbates peripheral neurological deficits
Triggering receptor expressed on myeloid cells-2 (TREM2) has been implicated in susceptibility to neurodegenerative disease. Schwann cells (SCs), the predominant glial cell type in the peripheral nervous system (PNS), play a crucial role in myelination, providing trophic support for neurons and nerve regeneration. However, the function of TREM2 in SCs has not been fully elucidated. Here, we found that TREM2 is expressed in SCs but not in neurons in the PNS. TREM2 deficiency leads to disruption of glycolytic flux and oxidative metabolism in SCs, impairing cell proliferation. The energy crisis caused by TREM2 deficiency triggers mitochondrial damage and autophagy by activating AMPK and impairing PI3K-AKT-mTOR signaling. Combined metabolomic analysis demonstrated that energic substrates and energy metabolic pathways were significantly impaired in TREM2-deficient SCs. Moreover, TREM2 deficiency impairs energy metabolism and axonal growth in sciatic nerve, accompanied by exacerbation of neurological deficits and suppression of nerve regeneration in a mouse model of acute motor axonal neuropathy. These results indicate that TREM2 is a critical regulator of energy metabolism in SCs and exerts neuroprotective effects on peripheral neuropathy.
- Open Access
The effect of adoptive transferring myeloid-derived suppressor cells in ventilator-induced lung injury mice
- Open Access
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 18 (4) , 921-928
Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study
Background: Although COVID-19 pneumonia is spreading internationally, knowledge regarding the factors associated with the illness severity of patients remains limited. We aimed to identify the factors associated with the disease severity of patients with COVID-19 pneumonia induced by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- 1 January 2021
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 18 (4) , 921-928
Open AccessRisk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study
Background: Although COVID-19 pneumonia is spreading internationally, knowledge regarding the factors associated with the illness severity of patients remains limited. We aimed to identify the factors associated with the disease severity of patients with COVID-19 pneumonia induced by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
- 21 October 2020
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 15 (1) , 41-44
Resonance assignments of La protein RRM domain from Trypanosoma brucei
The autoantigen La protein is a conserved component of eukaryotic ribonucleoprotein complexes that binds the 3′ poly(U) sequences of nascent RNA polymerase III transcripts to assist folding and maturation. This specific recognition is mediated by the N-terminal domain (NTD) of La, which comprises a La motif and an RNA recognition motif (RRM). Here, we report near complete 1H, 13C and 15N backbone and sidechain assignments for the RRM domain of La protein from Trypanosoma brucei.
- 21 October 2020
- Published by Springer Nature in Biomolecular NMR Assignments
- Vol. 15 (1) , 41-44
Resonance assignments of La protein RRM domain from Trypanosoma brucei
The autoantigen La protein is a conserved component of eukaryotic ribonucleoprotein complexes that binds the 3′ poly(U) sequences of nascent RNA polymerase III transcripts to assist folding and maturation. This specific recognition is mediated by the N-terminal domain (NTD) of La, which comprises a La motif and an RNA recognition motif (RRM). Here, we report near complete 1H, 13C and 15N backbone and sidechain assignments for the RRM domain of La protein from Trypanosoma brucei.
- 1 October 2020
- Published by Elsevier in Journal of Structural Biology
- Vol. 212 (1) , 107580
Solution structure of TbUfm1 from Trypanosoma brucei and its binding to TbUba5
- 1 October 2020
- Published by Elsevier in Journal of Structural Biology
- Vol. 212 (1) , 107580
Solution structure of TbUfm1 from Trypanosoma brucei and its binding to TbUba5
- Open Access
- 21 July 2020
- Published by Springer Nature in Research Square
Risk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study
Background Although COVID-19 pneumonia is spreading internationally, knowledge regarding the factors associated with the illness severity of patients remains limited. We aimed to identify the factors associated with the disease severity of patients with COVID-19 pneumonia induced by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods We prospectively enrolled a single-center case series of adult patients with COVID-19 admitted to the Infectious Disease Hospital of Jining, Jining City, Shandong Province, China, from January 24 to March 1, 2020. Demographics, clinical characteristics, and laboratory findings were compared to investigate the risk factors related with the disease severity of COVID-19 pneumonia patients. Results We included a total of 78 patients with COVID-19 pneumonia, of whom 6 had the severe type. As compared to a moderately ill cohort, our analysis showed that shortness of breath, fatigue, neutrophil percentages > 70%, neutrophil counts > 6.3 × 10 9 /L, lymphocyte percentages < 20%, lymphocyte counts < 1.0 × 10 9 /L, platelet < 100 × 10 9 /L, C-reactive protein (CRP) > 10 mg/L, neutrophil to platelet ratio (NPR) > 2.3, neutrophil to lymphocyte ratio (NLR) > 3.9, aspartate aminotransferase (AST) > 40 U/L, albumin < 40 g/L, lactate dehydrogenase (LDH) > 245 U/L, and glucose > 6.1 mmol/L were predictors of disease severity in COVID-19 pneumonia. In the sex-, age-, and comorbid illness-matched case-control study, neutrophil percentages > 70%, neutrophil counts > 6.3 × 10 9 /L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L remained associated with the early detection and identification of severe patients. Conclusion We demonstrated that neutrophil percentages > 70%, neutrophil counts > 6.3×10 9 /L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L might predict the severity of illness in patients with COVID-19 pneumonia.
- 21 July 2020
- Published by Springer Nature in Research Square
Open AccessRisk factors for illness severity in patients with COVID-19 pneumonia: a prospective cohort study
Background Although COVID-19 pneumonia is spreading internationally, knowledge regarding the factors associated with the illness severity of patients remains limited. We aimed to identify the factors associated with the disease severity of patients with COVID-19 pneumonia induced by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods We prospectively enrolled a single-center case series of adult patients with COVID-19 admitted to the Infectious Disease Hospital of Jining, Jining City, Shandong Province, China, from January 24 to March 1, 2020. Demographics, clinical characteristics, and laboratory findings were compared to investigate the risk factors related with the disease severity of COVID-19 pneumonia patients. Results We included a total of 78 patients with COVID-19 pneumonia, of whom 6 had the severe type. As compared to a moderately ill cohort, our analysis showed that shortness of breath, fatigue, neutrophil percentages > 70%, neutrophil counts > 6.3 × 10 9 /L, lymphocyte percentages < 20%, lymphocyte counts < 1.0 × 10 9 /L, platelet < 100 × 10 9 /L, C-reactive protein (CRP) > 10 mg/L, neutrophil to platelet ratio (NPR) > 2.3, neutrophil to lymphocyte ratio (NLR) > 3.9, aspartate aminotransferase (AST) > 40 U/L, albumin < 40 g/L, lactate dehydrogenase (LDH) > 245 U/L, and glucose > 6.1 mmol/L were predictors of disease severity in COVID-19 pneumonia. In the sex-, age-, and comorbid illness-matched case-control study, neutrophil percentages > 70%, neutrophil counts > 6.3 × 10 9 /L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L remained associated with the early detection and identification of severe patients. Conclusion We demonstrated that neutrophil percentages > 70%, neutrophil counts > 6.3×10 9 /L, lymphocyte percentages < 20%, NPR > 2.3, NLR > 3.9, albumin < 40 g/L, and LDH > 245 U/L might predict the severity of illness in patients with COVID-19 pneumonia.